References
- Carmine A A, Brodgen R N, Heel R C., et al. Tinidazole in anaerobic infection. A review of its antibacterial activity, pharmacological properties and therapeutic efficacy. Drugs 1982; 24: 85–117
- Nord C E, Kager L. Tinidazole-microbiology, pharmacology and efficacy in anaerobic infections. Infection 1983; 11: 54–60
- Bergan T. Antibacterial activity and pharmacokinetics of nitroimidazoles. A review. Scand J Infect Dis 1985; 46: 64–71, Suppl
- Jokipii A MM, Jokipii L. Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius. Antimicrob Agents Chemother 1987; 31: 183–6
- Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968; 50: 129–37
- Vaillant L, Machet L, Taburet A M., et al. Levels of furisidic acid in skin blister fluid and serum after repeated administration of two dosages (250 and 500 mg). Br J Dermatol 1992; 126: 591–5
- Klimowicz A, Nowak A, Kadyków M. Plasma and skin blister fluid concentrations of trimethoprim following its oral administration. Eur J Clin Pharmacol 1988; 34: 377–80
- Nowak A, Klimowicz A. Two-stage penetration of a single oral dose of sulphadimethoxine into skin blister fluid. Eur J Clin Pharmacol 1990; 39: 487–90
- Klimowicz A, Nowak A, Bielecka-Grzela S. Penetration of tinidazole into skin blister fluid following its oral administration. Eur J Clin Pharmacol 1992; 43: 523–6
- Wise R, Johnson J, O'Sullivan N., et al. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent. J Antimicrob Chemother 1991; 28: 905–9
- Korting H C, Schäfer-Korting M, Kees F., et al. Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetil. Eur J Clin Pharmacol 1990; 39: 33–6
- Wise R, Gillett A P, Cadge B., et al. The influence of protein binding upon tissue fluid levels of six β-lactams antibiotics. J Infect Dis 1980; 142: 77–82
- Mattila J, Männistö P T, Mäntylä R, et al. Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother 1983; 23: 721–5
- Bergan T, Solhaug J H, Soreide O., et al. Comparative pharmacokinetics of metronidazole and tinidazole and their tissue penetration. Scand J Gastroenterol 1985; 20: 945–50
- MustofaSuryawati S, Santoso B. Pharmacokinetics of metronidazole in saliva. Int J Clin Pharmacol Ther Toxicol 1991; 29: 474–8
- Taylor J A, Migliardi J R, von Wittenau Schach M. Tinidazole and metronidazole pharmacokinetics in man and mouse. Antimicrob Agents Chemother 1969; 267–70
- Wood S G, John B A, Chasseaud L F., et al. Pharmacokinetics and metabolism of 14C-tinidazole in humans. J Antimicrob Chemother 1986; 17: 801–9
- Sanvordeker D R, Chien Y W, Lin T K., et al. Binding of metronidazole and its derivatives to plasma proteins: an assessment of drug binding phenomenon. J Pharm Sci 1975; 64: 1797–803
- Schäfer-Korting M, Korting HCh. Skin blisters and skin windows: an access to total and free drug concentration in the skin. Models in dermatology, H I Maibach, N J Lowe. Karger, Basel 1989; vol 4.: 45–62
- Lever L, Marks R. Current views on aetiology, pathogenesis and treatment of acne vulgaris. Drugs 1990; 39: 681–92
- Kalkoff K W, Buck A. Zur Pathogenesis der perioralen Dermatitis. Hautarzt 1977; 28: 74–9
- Akamatsu H, Oguchi M, Nishijima S., et al. The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action in rosacea and acne. Arch Dermatol Res 1990; 282: 449–54